#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13874	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2084	654.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1393	1393	C	794	C	782	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13874	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2084	654.4	0	HET	.	.	.	C207T,G,A	.	207	207	C	416	416	C	784	C,T,G,A	584,164,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24904	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3722	663.4	0	.	n	.	0	T695C	SNP	695	695	T	1044	1044	C	765	C	756	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24904	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3722	663.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1987	1987	G	791	G,A	595,189	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24904	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3722	663.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2320	2320	C	792	C,T,A	770,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24904	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3722	663.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2394	2394	A	797	A	791	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24904	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3722	663.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2946	2946	C	753	C	742	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1822	folP	855	855	100.0	folP.l15.c30.ctg.1	1621	111.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1126	1128	AGC	165;169;170	A;G;C,T	165;169;165,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5400	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3463	154.5	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	175;178;177	T;T;C	175;176;173	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5400	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3463	154.5	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	183;184;183	G;G;C	179;184;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5400	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3463	154.5	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	183;184;183	G;G;C	179;184;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1486	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1345	109.1	1	SNP	p	G45D	0	.	.	133	135	GGC	488	490	GGC	188;187;187	G;G;C	186;185;185	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	784	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	969	79.9	0	.	n	.	0	A197.	DEL	197	197	A	522	522	A	182	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	151.4	1	SNP	p	D86N	0	.	.	256	258	GAC	605	607	GAC	195;195;198	G;A,G;C	192;185,2;196	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	151.4	1	SNP	p	S87R	1	.	.	259	261	CGT	608	610	CGT	197;199;202	C;G;T	196;196;199	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	151.4	1	SNP	p	R87W	0	.	.	259	261	CGT	608	610	CGT	197;199;202	C;G;T	196;196;199	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	151.4	1	SNP	p	R87I	0	.	.	259	261	CGT	608	610	CGT	197;199;202	C;G;T	196;196;199	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4566	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2984	151.4	1	SNP	p	S88P	0	.	.	262	264	TCC	611	613	TCC	207;206;206	T;C,T;C	201;202,1;203	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3832	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2581	146.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	199;193;193	G;G;C	198;193;189	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1339	1341	GCC	205;205;204	G;C;C	200;202;194	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1342	1344	ATG	207;205;203	A;T;G	203;198;198	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1354	1356	ACC	202;202;201	A;C;C	193;197;192	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1354	1356	ACC	202;202;201	A;C;C	193;197;192	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1855	1857	ACC	169;171;170	A;C;C,A	168;171;168,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1909	1911	GCG	163;161;164	G;C;G	159;159;162	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1909	1911	GCG	163;161;164	G;C;G	159;159;162	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2032	2034	GGT	141;140;136	G;G;T	140;136;133	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2041	2043	AGC	116;115;114	A,G;G;C	110,1;114;111	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3532	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2613	133.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2059	2061	CCG	105;107;107	C;C,G;G,T	99;103,1;92,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5174	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3250	157.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1662	1664	CCG	191;188;188	C,A;C,T;G	173,1;179,1;175	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2382	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1850	126.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	609	609	C	173	C	163	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	A251V	NONSYN	751	753	GCG	38	40	GTG	25;25;25	G;T;G,A	25;25;1,23	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	S271T	NONSYN	811	813	TCG	98	100	ACT	38;37;36	A;C;T	36;36;35	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	104	106	GAT	28;27;26	G;A;T	27;27;26	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	D276N	NONSYN	826	828	GAT	113	115	AAC	26;26;26	A;A;C	26;26;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	N277H	NONSYN	829	831	AAC	116	118	CAC	26;26;26	C;A;C	26;26;26	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	R307E	NONSYN	919	921	AGA	206	208	GAA	10;10;10	G;A;A	10;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	218	220	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	221	223	GAC	11;11;11	G;A;C	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	227	229	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	233	235	TCG	12;12;12	T;C;G	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	239	241	GCC	12;12;12	G;C;C	11;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	242	244	AGC	12;12;12	A,G;G;C	11,1;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	245	247	GCC	12;13;14	G;C;C	11;13;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	656	262	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	346	20.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	251	253	GTT	11;11;12	G;T;T	9;11;11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2540	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1730	145.4	1	SNP	p	G120K	1	.	.	358	360	AAG	770	772	AAG	190;189;192	A;A;G	183;189;180	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2540	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1730	145.4	1	SNP	p	A121N	1	.	.	361	363	AAC	773	775	AAC	192;190;189	A;A;C	189;188;182	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2540	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1730	145.4	1	SNP	p	N121D	0	.	.	361	363	AAC	773	775	AAC	192;190;189	A;A;C	189;188;182	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9188	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4934	184.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1048	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	998	103.3	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	199;200;203	A,C;T;G	195,1;199;198	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
